home All News open_in_new Full Article

Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes

Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per cent of people with Type 2 diabetes develop some form of chronic kidney disease. An international clinical trial, called FLOW, showed the risk of kidneys significantly deteriorating or failing was 24 […]


today 5 h. ago attach_file Society

attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Science
attach_file Science
attach_file Science
attach_file Events
attach_file Economics
attach_file Culture
attach_file Science
attach_file Events
attach_file Science
attach_file Sport
attach_file Other
attach_file Culture
attach_file Other


ID: 962277002
Add Watch Country

arrow_drop_down